#EmcurePharma reports its #Q1 earnings:

👉Net Profit Up 44% At ₹207 Cr Vs ₹144 Cr (YoY)

👉Revenue Up 15.7% At ₹2,100 Cr Vs ₹1,815 Cr (YoY)

👉EBITDA Up 24% At ₹417 Cr Vs ₹336.4 Cr (YoY)

👉Margin At 20% Vs 18.5% (YoY)